Biogen strikes back at investor lawsuit on Aduhelm launch flop

[anonymous]

Biogen strikes back at investor lawsuit on Aduhelm launch flop


Biogen deflects claims it misled shareholders about Aduhelm's success

 

[anonymous]

Uh, huh.


“While the company admits its Aduhelm rollout was a dud, it countered that the investors’ lawsuit fails to show the company concealed insights into the downturn its stock would take amid the fallout of the drug’s launch.

The drug’s approval was a “source of enormous hope for Biogen on behalf of patients and the company,” while its flop of out the gate was a “source of great disappointment,” the company's lawyers added in its court filings. Still, Biogen asserts, it never promised the drug would become a “commercial success.””

 

[anonymous]

Sure. No company implies that a new product will be a commercial success. They usually say the brand will fall flat on its face. That’s what they’re bringing it to the market in the first place.